The Association Between Total Prostate Specific Antigen Concentration and Prostate Specific Antigen Velocity

Journal of Urology

Volumn 177, Issue 4, 2007, Pages 1298-1302

  Yu, Xiaoying ^a   Loeb, Stacy ^b   Roehl, Kimberly A ^c   Han, Misop ^a   Catalona, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antitumor; drug screening assays; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGEN DETECTION; ARTICLE; CALCULATION; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CHI SQUARE TEST; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; KRUSKAL WALLIS TEST; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN VELOCITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 33947206065     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.12.003     Document Type: Article

References (7)

1. Catalona W.J., Smith D.S., Ratliff T.L., Dodds K.M., Coplen D.E., Yuan J.J., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 (1991) 1156
2. Carter H.B., Pearson J.D., Metter E.J., Brant L.J., Chan D.W., Andres R., et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267 (1992) 2215
3. D'Amico A.V., Renshaw A.A., Sussman B., and Chen M.H. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 294 (2005) 440
4. D'Amico A.V., Chen M.H., Roehl K.A., and Catalona W.J. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351 (2004) 125
5. Smith D.S., and Catalona W.J. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 152 (1994) 1732
6. Thompson I.M., Ankerst D.P., Chi C., Goodman P.J., Tangen C.M., Lucia M.S., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 (2006) 529
7. Sengupta S., Myers R.P., Slezak J.M., Bergstralh E.J., Zincke H., and Blute M.L. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. J Urol 174 (2005) 2191